HOC

HOC is a diversified pharmaceutical and biotechnology company focused on developing and commercializing high-quality therapeutic solutions across multiple disease areas. The company maintains a robust portfolio that includes both innovative biologics and specialized small molecule drugs, with a particular emphasis on immunology and oncology. HOC operates with a global reach, leveraging strategic partnerships to expand its pipeline and market presence. Their business model integrates research and development with large-scale manufacturing and commercial distribution. By focusing on unmet medical needs, HOC aims to improve patient outcomes through accessible and effective healthcare products.